Cargando…

Antimalarials – are they effective and safe in rheumatic diseases?

Antimalarial drugs (AD) are a group of widespread therapeutic agents in multiple rheumatic indications. Although the effect of AD is mild and extended in time, low toxicity is their appreciated value. This paper describes the current state of knowledge on the mechanism of action, use, toxicity and p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haładyj, Ewa, Sikora, Mariusz, Felis-Giemza, Anna, Olesińska, Marzena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2018
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052376/ https://www.ncbi.nlm.nih.gov/pubmed/30042604 http://dx.doi.org/10.5114/reum.2018.76904

Ejemplares similares

Treatment of rheumatic diseases and hepatitis B virus coinfection
por: Felis-Giemza, Anna, et al.
Publicado: (2014)

Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome
por: Haładyj, Ewa, et al.
Publicado: (2016)

Relationship between type of skin lesions and nailfold capillaroscopy pattern in mixed connective tissue disease
por: Felis-Giemza, Anna, et al.
Publicado: (2021)

IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases
por: Wojdasiewicz, Piotr, et al.
Publicado: (2019)

Rivaroxaban – a safe therapeutic option in patients with antiphospholipid syndrome? Our experience in 23 cases
por: Haładyj, Ewa, et al.
Publicado: (2016)

Capillaroscopy – a role in modern rheumatology
por: Chojnowski, Marek M., et al.
Publicado: (2016)

Interleukin 6 blockage-induced neutropenia in a patient with rheumatoid arthritis and resolved hepatitis B
por: Chmielińska, Magdalena, et al.
Publicado: (2016)

Microvascular damage – a marker of specific organ involvement in mixed connective tissue disease?
por: Ornowska, Sylwia, et al.
Publicado: (2021)

Is intra-articular infliximab therapy a good alternative to radionuclide synovectomy for a patient with refractory pigmented villonodular synovitis?
por: Felis-Giemza, Anna, et al.
Publicado: (2021)

Potential Mechanism of Fatigue Induction and Its Management by JAK Inhibitors in Inflammatory Rheumatic Diseases
por: Felis-Giemza, Anna, et al.
Publicado: (2023)

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
por: Felis-Giemza, Anna, et al.
Publicado: (2019)

Association study between immune-related miRNAs and mixed connective tissue disease
por: Stypińska, Barbara, et al.
Publicado: (2021)

Antimalarials – are they effective and safe in rheumatic disease? Focus on the neuropsychiatric side effects
por: Manzo, Cirro
Publicado: (2018)

The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding
por: Romanowska-Próchnicka, Katarzyna, et al.
Publicado: (2021)

Interferons (IFN-A/-B/-G) Genetic Variants in Patients with Mixed Connective Tissue Disease (MCTD)
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2019)

Impact of Adipose-Derived Mesenchymal Stem Cells (ASCs) of Rheumatic Disease Patients on T Helper Cell Differentiation
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2022)

Impact and Possible Mechanism(s) of Adipose Tissue-Derived Mesenchymal Stem Cells on T-Cell Proliferation in Patients With Rheumatic Disease
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2022)

Discrepancies in assessment of patients with rheumatoid arthritis and secondary Sjögren's syndrome by DAS28-ESR and DAS28-CRP
por: Romanowska-Próchnicka, Katarzyna, et al.
Publicado: (2016)

Mixed Connective Tissue Disease as Different Entity: Global Methylation Aspect
por: Filipowicz, Gabriela, et al.
Publicado: (2023)

New era of treatment with biologics in rheumatology – is it time to shift paradigms in treatment with biologics?
por: Felis-Giemza, Anna
Publicado: (2019)

Modulation of T-Cell Activation Markers Expression by the Adipose Tissue–Derived Mesenchymal Stem Cells of Patients with Rheumatic Diseases
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2020)

Satisfaction and discontent of Polish patients with biological therapy of rheumatic diseases: results of a multi-center questionnaire study
por: Kotulska, Anna, et al.
Publicado: (2018)

Coronavirus disease 2019 vaccination uptake and hesitancy among Polish patients with inborn errors of immunity, autoinflammatory syndromes, and rheumatic diseases: A multicenter survey
por: Więsik-Szewczyk, Ewa, et al.
Publicado: (2022)

Radionuclide synovectomy – essentials for rheumatologists
por: Chojnowski, Marek M., et al.
Publicado: (2016)

The Role of MECP2 and CCR5 Polymorphisms on the Development and Course of Systemic Lupus Erythematosus
por: Rzeszotarska, Ewa, et al.
Publicado: (2020)

RORC2 Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2016)

FLT-1 gene polymorphisms and protein expression profile in rheumatoid arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2017)

The Phenotype and Secretory Activity of Adipose-Derived Mesenchymal Stem Cells (ASCs) of Patients with Rheumatic Diseases
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2019)

Relationship between VEGF Gene Polymorphisms and Serum VEGF Protein Levels in Patients with Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2016)

Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic
por: Grygiel-Górniak, Bogna
Publicado: (2021)

Quality of life in systemic lupus erythematosus and its measurement
por: Olesińska, Marzena, et al.
Publicado: (2018)

Do we still need renal biopsy in lupus nephritis?
por: Haładyj, Ewa, et al.
Publicado: (2016)

Liver involvement in rheumatic diseases
por: Podgórska, Joanna, et al.
Publicado: (2020)

Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes
por: Ciechomska, Marzena, et al.
Publicado: (2023)

Differential diagnosis of idiopathic inflammatory myopathies in adults – the first step when approaching a patient with muscle weakness
por: Szczęsny, Piotr, et al.
Publicado: (2018)

Esophageal transit scintigraphy in systemic sclerosis
por: Chojnowski, Marek, et al.
Publicado: (2016)

Recognizing systemic sclerosis: comparative analysis of various sets of classification criteria
por: Romanowska-Próchnicka, Katarzyna, et al.
Publicado: (2016)

Subgroups of Sjögren’s syndrome patients categorised by serological profiles: clinical and immunological characteristics
por: Kontny, Ewa, et al.
Publicado: (2018)

Antimalarials – old drugs are new again
por: Woźniacka, Anna
Publicado: (2021)

Repeat renal biopsy in lupus nephritis – unnecessary harm and risk of complications or important diagnostic tool with clinical consequences?
por: Haładyj, Ewa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mr4gtp56dtg7f293lgkqvsvaeo